All Articles

Choice Hotels' Everhome brand crosses the 25-property mark, signaling its leadership in the rapidly expanding and highly competitive extended stay sector.

Investors sue medical device maker Integer Holdings, alleging misleading statements led to a catastrophic 32% stock drop. What went wrong behind the scenes?

Cybersecurity firm Cynet appoints industry veteran MacKenzie Brown to translate complex threat data into practical, actionable intelligence for MSP partners.

The safety giant is launching its 35-2X Series gas ignition controls, targeting Europe and APAC's booming HVAC, ag, and cooking equipment markets.

The iconic F1 team is integrating Anthropic's Claude AI to navigate 2026's massive rule changes, aiming to outthink rivals and return to the top.

Following strong Texas sales, cbdMD brings its Herbal Oasis THC seltzer to Louisiana, betting on a market eager for functional alcohol alternatives.

Cabot Corp's purchase of a key Bridgestone facility in Mexico is a strategic play to dominate the reinforcing carbons market and secure vital supply chains.

A major private equity investment in The Forge Companies signals a shift toward integrated financial planning for a complex and fragmented settlement market.

From automated bookings to data-driven operations, a new tech tide is rising, promising greater efficiency for operators and better experiences for boaters.

A new report warns one in five malware infections will expose corporate logins by late 2026 as attackers pivot to high-value enterprise identity platforms.

With its largest fund yet, the firm is doubling down on breakthrough biotech and medtech, signaling strong investor faith in deep science innovation.

Burberry and Coty launch Hero Elixir, a potent new fragrance exploring duality and competing in the high-stakes, ultra-premium men's scent market.

With a massive new investment, CyberFOX plans to accelerate AI development and acquisitions, aiming to reshape the security landscape for underserved MSPs.

A new deal with Sourcewell lets Alliant streamline insurance for 50,000+ public agencies, cutting red tape and boosting risk management nationwide.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

A new AI embedded in smart meters detects grid faults in real time, promising to stop wildfires and power outages before they start. Here's how it works.

At MD&M West 2026, Boyd showcases how materials science and regulatory expertise are the unsung heroes behind the next wave of medical wearables.

A $2.5B revitalization project enters a new phase, as Vornado and Newmark aim to transform a transit hub into NYC's premier 24/7 destination.

The firm's strategic relocation to an amenity-rich retail hub signals deep confidence in the Sunbelt and a new vision for the modern corporate office.